Form 4: Iridex CFO Romeo Dizon Buys 2,000 Shares

Rhea-AI Filing Summary

Iridex Corp (IRIX) Form 4: Chief Financial Officer Romeo Dizon reported two purchases on 08/21/2025 totaling 2,000 shares of common stock. The first purchase was 1,000 shares at $1.27 and the second was 1,000 shares at $1.22. Beneficial ownership increased to 46,745 shares following the transactions. The form was signed 08/22/2025 by an attorney-in-fact.

Positive

• Reporting person acquired 2,000 common shares (1,000 at $1.27 and 1,000 at $1.22) on 08/21/2025
• Beneficial ownership updated to 46,745 shares following the reported transactions
• Form includes required signature via attorney-in-fact dated 08/22/2025

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider purchases of 2,000 shares by the CFO were reported, with specific prices and updated beneficial ownership.

The Form 4 discloses two non-derivative purchases by Romeo Dizon on 08/21/2025: 1,000 shares at $1.27 and 1,000 shares at $1.22, bringing his reported beneficial ownership to 46,745 shares. Transactions are straightforward purchases (code P) and are properly documented with an attorney-in-fact signature dated 08/22/2025. No derivatives or other arrangements are reported.

Corporate Governance Expert

TL;DR: Filing shows routine insider purchase disclosures by a named officer with required signature and dates.

The submission identifies Romeo Dizon as Chief Financial Officer and reports purchases executed on 08/21/2025. The Form 4 is filed by one reporting person and includes the reporting person’s address. The document contains required signatures and explanations fields, with no amendments indicated. There are no derivative transactions or additional disclosures in the filing.

Insider Trade Summary

Net Buyer: 2,000 shares ($2,490)

Net Buy 2 txns

Insider Dizon Romeo R

Role Chief Financial Officer

Bought 2,000 shs ($2K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,000	$1.27	$1K
Purchase	Common Stock	1,000	$1.22	$1K

Holdings After Transaction: Common Stock — 45,745 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CA 94043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/21/2025		P		1,000	A	$1.27	45,745	D
Common Stock	08/21/2025		P		1,000	A	$1.22	46,745	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nilo De Castro, Attorney-in-fact for Romeo Dizon	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did IRIX CFO Romeo Dizon report on the Form 4?

He reported two purchases on 08/21/2025: 1,000 shares at $1.27 and 1,000 shares at $1.22.

How many shares does Romeo Dizon beneficially own after the reported trades?

46,745 shares of Iridex Corp common stock following the transactions.

What type of filing was submitted for IRIX and who signed it?

Form 4 was filed reporting insider changes and was signed by an attorney-in-fact, Nilo De Castro, on 08/22/2025.

Were any derivative securities reported in this Form 4 for IRIX?

No derivatives are reported; Table II contains no entries for derivative securities.

Was the Form 4 filed by multiple reporting persons?

No; the form indicates it was filed by one reporting person.